Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Jeffrey L. Watts"'
Publikováno v:
Biomolecules, Vol 8, Iss 4, p 166 (2018)
Antibiotic discovery is vital when considering the increasing antimicrobial resistance threat. The aim of this work was to provide a high-throughput screen (HTS) assay using multidrug-resistant Escherichia coli strains to enable further research into
Externí odkaz:
https://doaj.org/article/170a9cfaa0724c38ba35b4ca417713f5
Autor:
Carmen Sadaka, Edmund Ellsworth, Paul Robert Hansen, Richard Ewin, Peter Damborg, Jeffrey L. Watts
Publikováno v:
Molecules, Vol 23, Iss 6, p 1371 (2018)
Antifolates targeting folate biosynthesis within the shikimate-chorismate-folate metabolic pathway are ideal and selective antimicrobials, since higher eukaryotes lack this pathway and rely on an exogenous source of folate. Resistance to the availabl
Externí odkaz:
https://doaj.org/article/4b227672199a4f09813734c1a83e9091
Autor:
Ines Greco, Bernard D. Hummel, Jaspreet Vasir, Jeffrey L. Watts, Jason Koch, Johannes E. Hansen, Hanne Mørck Nielsen, Peter Damborg, Paul R. Hansen
Publikováno v:
Molecules, Vol 23, Iss 3, p 630 (2018)
Antimicrobial peptides (AMPs) hold promise as the next generation of antimicrobial agents, but often suffer from rapid degradation in vivo. Modifying AMPs with non-proteinogenic residues such as peptoids (oligomers of N-alkylglycines) provides the po
Externí odkaz:
https://doaj.org/article/64a07e1c773342c589278a9e685829a6
Publikováno v:
Journal of Veterinary Pharmacology and Therapeutics. 44:207-214
The emergence of antimicrobial resistance in human and veterinary bacterial pathogens has led to concerns regarding the use of antimicrobials in veterinary medicine. Consequently, regulatory agencies have developed procedures for assessing the risk a
Publikováno v:
The Veterinary Journal. 248:79-85
The emergence of multi-drug resistant bacteria has limited therapeutic options for the treatment of bacterial diseases in both human and veterinary medicine. This has resulted in an urgent need for novel agents to treat infectious diseases. Veterinar
Publikováno v:
Journal of Veterinary Pharmacology and Therapeutics. 44:991-992
Autor:
Paul R. Hansen, Bernard D Hummel, Elin Holmedal, Jeffrey L. Watts, Johan Svenson, Håvard Jenssen, Natalia Molchanova, Joakim Håkansson, Ines Greco
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Greco, I, Molchanova, N, Holmedal, E, Jenssen, H, Hummel, B D, Watts, J L, Håkansson, J, Hansen, P R & Svenson, J 2020, ' Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of synthetic antimicrobial peptides ', Scientific Reports, vol. 10, 13206 . https://doi.org/10.1038/s41598-020-69995-9
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Greco, I, Molchanova, N, Holmedal, E, Jenssen, H, Hummel, B D, Watts, J L, Håkansson, J, Hansen, P R & Svenson, J 2020, ' Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of synthetic antimicrobial peptides ', Scientific Reports, vol. 10, 13206 . https://doi.org/10.1038/s41598-020-69995-9
The use of non-standard toxicity models is a hurdle in the early development of antimicrobial peptides towards clinical applications. Herein we report an extensive in vitro and in vivo toxicity study of a library of 24 peptide-based antimicrobials wi
Autor:
Andrea T. Feßler, Thomas Peters, Stefan Schwarz, Heike Kaspar, Jeffrey L. Watts, Cynthia J. Lindeman
Publikováno v:
Veterinary Microbiology. 200:65-70
Cefoperazone is a third generation cephalosporin which is commonly used for bovine mastitis therapy. Bacterial pathogens involved in bovine mastitis are frequently tested for their susceptibility to cefoperazone. So far, the cefoperazone susceptibili
Publikováno v:
Journal of Clinical Microbiology
Sadaka, C, Kanellos, T, Guardabassi, L, Boucher, J & Watts, J L 2017, ' Evaluation of Veterinary-Specific Interpretive Criteria for Susceptibility Testing of Streptococcus equi Subspecies with Trimethoprim-Sulfamethoxazole and Trimethoprim-Sulfadiazine ', Journal of Clinical Microbiology, vol. 55, no. 1, pp. 326-330 . https://doi.org/10.1128/JCM.01610-16
Sadaka, C, Kanellos, T, Guardabassi, L, Boucher, J & Watts, J L 2017, ' Evaluation of Veterinary-Specific Interpretive Criteria for Susceptibility Testing of Streptococcus equi Subspecies with Trimethoprim-Sulfamethoxazole and Trimethoprim-Sulfadiazine ', Journal of Clinical Microbiology, vol. 55, no. 1, pp. 326-330 . https://doi.org/10.1128/JCM.01610-16
Antimicrobial susceptibility test results for trimethoprim-sulfadiazine with Streptococcus equi subspecies are interpreted based on human data for trimethoprim-sulfamethoxazole. The veterinary-specific data generated in this study support a single br